Alcala, Mary Jane A.
HRN: 24-13-41 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/25/2024
CEFUROXIME 1.5GM (VIAL)
01/25/2024
01/31/2024
IV
1.5g
Q8H
Cholelithiasis
Waiting Final Action
01/25/2024
CEFUROXIME 1.5GM (VIAL)
01/25/2024
01/31/2024
IV
1.5g
Q8H
Cholelithiasis
Waiting Final Action